J Addict Med 2014 Mar-Apr;8(2):123-9
From the Neuroimaging and Analysis Group (HTJ, HE, HG, PHA, MAO, AM), Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran; Neurocognitive Laboratory (HTJ, HE, HG, PHA, AM), Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Institute for Cognitive Sciences Studies (HE, PHA, MZ), Tehran, Iran; Interventional and Contemporary Radiology Research Center (MAO, NS), Tehran University of Medical Sciences, Tehran, Iran; and Department of Neurology (MZ), University of Nottingham, Nottingham, United Kingdom.